Neuland Laboratories Limited has informed the Exchange regarding 'Business Responsibility and Sustainability Report for FY 2024-25'.

Neuland Laboratories has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2024-25, as required under SEBI's Listing Regulations. The company reported a turnover of ₹1,47,684 lakhs, a net worth of ₹1,51,692 lakhs, and spent ₹525.04 lakhs on CSR activities. Neuland exports about 68% of its revenue to 61 countries and manufactures 100% of its products in Active Pharmaceutical Ingredients (APIs). It employs 1,991 people (including contract staff) and has reduced permanent employee turnover to 16.81% from 18.42% the previous year. The company has been running a zero-effluent discharge system for over three years, is pursuing SBTi validation for emissions, completed green chemistry and life cycle assessments, and obtained third-party assurance from TUV India. No fines, penalties, or disciplinary actions for corruption or conflicts of interest were reported during the year.